Veterinary/Animal Vaccines Market Reaching at CAGR of 5.8% to 2021

The veterinary/animal vaccines market is to reach USD 7.68 billion by 2021 at CAGR of 5.8% from 2016 to 2021 led by companion animal vaccines due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.

Pune, India – August 12, 2016 /MarketersMedia/ —

Complete report on global veterinary/animal vaccines market across 188 pages, profiling 10 companies and supported with 144 tables and 73 figures is now available at http://www.rnrmarketresearch.com/animalveterinary-vaccines-market-products-livestock-bovine-companion-canine-poultry-equine-diseases-rabies-distemper-foot-mouth-gumboro-avian-influenza-strangles-technology-live-market-report.html .

In this market, primary investment opportunities are in emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India; these are lucrative markets for veterinary vaccines, owing to favorable government initiatives.

The report segments the veterinary/animal vaccines market on the basis of products, diseases, technologies, and region. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.

The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to account for the highest growth of the veterinary vaccines market in 2016, due to innovations in technology and increased public awareness about animal vaccination.

New and innovative product launches and collaboration were the dominant strategies adopted by companies in veterinary/animal vaccines market.

This research report focuses on qualitative data, market size, and the growth of various segments and sub segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives. The competitive landscape covers growth strategies adopted by industry players in the last three years. Company profiles comprise basic views on key players in the veterinary vaccines market and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in pr
oducts and technologies, and levels of output in order to remain successful.

Key players operating in the veterinary/animal vaccines market are Zoetis Inc. (Pfizer) (U.S.), Merck Animal Health (U.S.), Merial Inc. (France), Boehringer Ingelheim (Germany), Bayer Animal Health (Germany), Elanco Animal Health (U.S.), Ceva Animal Health (France), Heska Corporation (U.S.), and Virbac Inc. (France). Request a discount on Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) – Forecast to 2021 research report available at http://www.rnrmarketresearch.com/contacts/discount?rname=113081 .

From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the veterinary vaccines market; high-growth regions; and market drivers, restraints, and opportunities.

On a related note, another research on Vaccines Market Forecasts to 2021 says, the vaccines market is expected to reach USD48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The major factors contributing to the growth of the vaccines market include high prevalence of diseases; rising government and nongovernment funding for vaccine development, and increasing focus on immunization programs. Companies like Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., GlaxoSmithKline, plc., Johnson & Johnson, MedImmune, LLC, Merck & Co., Pfizer, Inc., Sanofi Pasteur and Serum Institute of India Pvt. Ltd. have been profiled in this 158 pages research report available http://www.rnrmarketresearch.com/vaccine-market-by-technology-types-trend-analysis-by-various-classes-live-attenuated-subunit-toxoid-conjugate-dna-recombinant-vector-synthetic-dentritic-vaccines-and-by-indications-i-market-report.html .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

For more information, please visit http://www.rnrmarketresearch.com

Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Phone: +1-888-391-5441

Source: http://marketersmedia.com/veterinaryanimal-vaccines-market-reaching-at-cagr-of-5-8-to-2021/127682

Release ID: 127682

Go Top